Tritoqualine
From Wikipedia, the free encyclopedia
 |
|
|---|---|
| Systematic (IUPAC) name | |
| 7-amino-4,5,6-triethoxy-3-(4-methoxy-6-methyl-7,8-dihydro-5H-[1,3]dioxolo[4,5-g]isoquinolin-5-yl)-3H-isobenzofuran-1-one | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 14504-73-5 |
| ATC code | ? |
| PubChem | CID 72145 |
| ChemSpider | 65119 |
| UNII | F4MW5166YH  |
| Chemical data | |
| Formula | C26H32N2O8 |
| Mol. mass | 500.54 g/mol |
| SMILES | eMolecules & PubChem |
Tritoqualine, also known as hypostamine, is an inhibitor of the enzyme histidine decarboxylase and therefore an atypical antihistamine, used for the treatment of urticaria and allergic rhinitis[1] with no known adverse effects.
[edit] References
- ^ Randomized, placebo controlled study of tritoqualine (hypostamine*) in the treatment of perennial allergic rhinitis. A. Pradalier, V. Hentschel, S. Prouzeau, D. Legallais, G. Lefrançois. Revue Française d’Allergologie et d’Immunologie Clinique 43:175-179 (2003)
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
